Advertisement

Abstract

Extreme thrombocytosis is noted in a variety of clinical situations. The potential for complications appears to be related to the underlying clinical problem, rather than to the absolute platelet count alone. For example, extreme thrombocytosis represents a potentially ominous complication of a number of hematologic disorders, including polycythemia vera and essential thrombocytosis, and may be associated with thrombotic or hemorrhagic complications. Even in these disorders, however, thrombocytosis may be entirely asymptomatic; therefore, the treatment of extreme thrombocytosis in the asymptomatic patient remains controversial. However, symptomatic patients appear to benefit from the lowering of the platelet count or the use of antiplatelet medication or both. Table 1 lists the disorders associated with thrombocytosis.

Keywords

Chronic Myelogenous Leukemia Iron Deficiency Anemia Polycythemia Vera Thrombotic Complication Myeloproliferative Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wintrobe MM, Lee GR, Boggs DR, et al (eds.): Thrombocytosis, in Clinical Hematology, 8th ed. Philadelphia, Lea and Febiger, 1981, pp 1128–1134.Google Scholar
  2. 2.
    Alexander MB: Iron deficiency anemia, thrombocytosis and cerebrovascular accident. South Med J 76: 662–665, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Mall T, Schmitt HE, Widner LK: Arterial occlusions in iron deficiency anemia with thrombocytosis. VASA 14: 188–190, 1985.PubMedGoogle Scholar
  4. 4.
    Hirsh J, McBride JA, Dacie JV: Thromboembolism and increased platelet adhesiveness in post-splenectomy thrombocytosis. Aust Ann Med 15: 122–129, 1966.PubMedGoogle Scholar
  5. 5.
    Coon WW, Penner J, Claggett P, Eos N: Deep venous thrombosis and postsplenectomy thrombocytosis. Arch Surg 113: 429–431, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Boxer MA, Braun J, Ellman L: Thromboembolic risk of postsplenectomy thrombocytosis. Arch Surg 113: 808–809, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Trousseau A: Phlegmasia alba dolens. Clinique Médicale de l’Hotel-Dieu de Paris, London. New Sydenham Society 3: 94–98, 1865.Google Scholar
  8. 8.
    Sack GH, Levin J, Bell WR: Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasma: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 56: 1–37, 1977.Google Scholar
  9. 9.
    Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62: 14–31, 1983.PubMedGoogle Scholar
  10. 10.
    Shafer AI: The hypercoagulable states. Ann Intern Med 102: 814–828, 1985.CrossRefGoogle Scholar
  11. 11.
    Shafer AI: Bleeding and thrombosis in the myeloproliferative disorders. Blood 64: 1–12, 1984.Google Scholar
  12. 12.
    Kessler CM, Klein HG, Havlik RJ: Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol 50: 157–167, 1982.PubMedCrossRefGoogle Scholar
  13. 13.
    Mitchell MC, Boitnott JK, Kaufman S, Cameron JL, Maddrey WC: Budd-Chiari syndrome: Etiology, diagnosis, and management. Medicine (Baltimore) 61: 199–218, 1982.Google Scholar
  14. 14.
    Fitts, WT Jr, Erde A, Peskin GW, Frost JW: Surgical implications of polycythemia vera. Ann Surg 152: 548–552, 1960.PubMedGoogle Scholar
  15. 15.
    Michiels JJ, Abels J, Steketee J, Van Ulict HHDM, Vuzevski VD: Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 102: 466–471, 1985.PubMedCrossRefGoogle Scholar
  16. 16.
    Preston FE, Martin JF, Stewart RM, Davies-Jones GAB: Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. Br Med J 2: 1561–1563, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Jabaily J, Hand HJ, Laszlo J, et al: Neurologic manifestations of essential thrombocythemia. Ann Intern Med 99: 513–518, 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Virmani R, Popovsky MA, Roberts WC: Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med 67: 498–506, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Bjorkholm M, Mellstedt H, Sawe U: Essential thrombocythaemia and polycythaemia vera presenting with pulmonary embolism mimicing pneumonia: Case reports. Haematologia 66: 667672, 1981.Google Scholar
  20. 20.
    Davis RB: Acute thrombotic complications of myeloproliferative disorders in young adults. Am J Clin Pathol 84: 180–185, 1985.Google Scholar
  21. 21.
    Spaet TH, Lejnieks I, Gaynor E, Goldstein ML: Defective platelets in essential thrombocythemia. Arch Intern Med 124: 135–141, 1969.PubMedCrossRefGoogle Scholar
  22. 22.
    Kaywin P, McDonough M, Insel PA, Shattil SJ: Platelet function in essential thrombocythemia. N Engl J Med 299: 505–509, 1978.PubMedCrossRefGoogle Scholar
  23. 23.
    Phadke K, Dean S, Pitney WR: Platelet dysfunction in myeloproliferative syndromes. Am J Hematol 10: 57–61, 1981.PubMedCrossRefGoogle Scholar
  24. 24.
    Zucker S, Mielke CH: Classification of thrombocytosis based on platelet function tests: Correlation with hemorrhagic and thrombotic complications. J Lab Clin Med 80: 385–394, 1972.PubMedGoogle Scholar
  25. 25.
    Wu KK: Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med 88: 7–12, 1978.PubMedCrossRefGoogle Scholar
  26. 26.
    Wasserman LR, Goldberg JD, Balcerzak SP, et al, for the Polycythemia Vera Study Group: Influence of therapy on causes of death in polycythemia vera. Clin Res 29: 573A, 1981.Google Scholar
  27. 27.
    Tartaglia AD, Goldberg JD, Silverstein MN, et al: Aspirin and persantine do not prevent thrombotic complications in patients with polycythemia vera treated with phlebotomy. Blood 58 (Suppl 1): 240a, 1981.Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Janice P. Dutcher
    • 1
    • 2
  1. 1.Department of Medicine, Division of Medical OncologyAlbert Einstein College of MedicineBronxUSA
  2. 2.Department of OncologyMontefiore Medical CenterBronxUSA

Personalised recommendations